Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma. [electronic resource]
Producer: 20141020Description: 60-7 p. digitalISSN:- 1085-5629
- Antineoplastic Agents -- therapeutic use
- CTLA-4 Antigen -- antagonists & inhibitors
- Humans
- Immunologic Factors -- therapeutic use
- Immunotherapy
- Interferon-alpha -- therapeutic use
- Interleukin-2 -- therapeutic use
- Melanoma -- genetics
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Molecular Targeted Therapy
- Mutation
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Proto-Oncogene Proteins c-kit -- genetics
- Skin Neoplasms -- genetics
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.